※ 출처: ClinicalTrials.gov
총 256건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy Carcinoma, Non-small Cell Lung Cancer Biological: nivolumab|Biological: ipilimumab|Drug: cabozantinib|Biological: docetaxel|Biological: ramucirumab|Drug: lucitanib Bristol-Myers Squibb|Clovis Oncology, Inc.|Exelixis|Eli Lilly and Company Phase 1|Phase 2 2021-04-15
2 Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049) Papillomavirus Infections Biological: 9vHPV Vaccine|Other: Placebo (Saline for Injection) Merck Sharp & Dohme Corp. Phase 3 2020-02-27
3 Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus (SLE) Drug: AMG 570|Drug: Placebo for AMG 570 Amgen Phase 2 2020-02-19
4 A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation Carcinoma, Hepatocellular Drug: Atezolizumab|Drug: Bevacizumab Hoffmann-La Roche Phase 3 2019-12-31
5 Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc) Diffuse Cutaneous Systemic Sclerosis Biological: IgPro10|Biological: Placebo CSL Behring Phase 2 2019-12-20
6 A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer Prostate Cancer Biological: nivolumab|Drug: prednisone|Drug: docetaxel Bristol-Myers Squibb Phase 3 2019-12-06
7 A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis Spondyloarthritis Drug: Upadacitinib|Drug: Placebo AbbVie Phase 3 2019-11-26
8 Long-Term Safety and Antibody Persistence of TDV and Impact of a Booster Dose Dengue Fever Biological: Tetravalent Dengue Vaccine (TDV)|Biological: Placebo Takeda Phase 3 2019-11-12
9 A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals Healthy Biological: Ad26.Mos4.HIV|Biological: Clade C and Mosaic gp140 HIV bivalent vaccine|Biological: Placebo Janssen Vaccines & Prevention B.V. Phase 3 2019-10-31
10 Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis Atopic Dermatitis Biological: Lebrikizumab|Other: Placebo Eli Lilly and Company|Dermira, Inc. a wholly owned subsidiary of Eli Lilly and Company Phase 3 2019-10-29